Damora Therapeutics (DMRA) Return on Capital Employed [ROCE] (2020 - 2026)
Damora Therapeutics' Return on Capital Employed [ROCE] was -52.87% in Q2 2026, up 89.68 percentage points from -142.55% a year earlier and up 11.03 percentage points from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Damora Therapeutics came in at -177.61%, down 93.54 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for five consecutive years, with a five-year change of -146.61 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -84.07% in FY2024 (-4.06 pp), -80.01% in FY2023 (-9.32 pp), -70.68% in FY2022 (-34.00 pp) and -36.69% in FY2021 (-5.69 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q1 2022.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in three of the last eight quarters, with an average year-over-year change of -5.99 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 89.68 percentage points); the worst was Q3 2025 (a drop of 74.39 percentage points).
- Per Business Quant data, DMRA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -63.90% (Q1 2026), -182.52% (Q4 2025) and -169.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Damora Therapeutics | 1.49 Bn | -364.52 Mn | - | -60.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -60.60% |
| Jun 30, 2026 | -52.87% |
| Mar 31, 2026 | -63.90% |
| Dec 31, 2025 | -182.47% |
| Sep 30, 2025 | -169.73% |
| Jun 30, 2025 | -142.55% |
| Mar 31, 2025 | -130.51% |
| Dec 31, 2024 | -116.83% |
| Sep 30, 2024 | -95.34% |
| Jun 30, 2024 | -101.51% |
| Mar 31, 2024 | -103.61% |
| Dec 31, 2023 | -104.17% |
| Sep 30, 2023 | -111.79% |
| Jun 30, 2023 | -110.64% |
| Mar 31, 2023 | -105.38% |
| Dec 31, 2022 | -92.04% |
| Sep 30, 2022 | -77.86% |
| Jun 30, 2022 | -64.74% |
| Mar 31, 2022 | -51.32% |
| Dec 31, 2021 | -41.95% |
API Access
Damora Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();